MengHee Tan, MD, FACP, FRCP [C], [L], [E], FACE, is Professor Emeritus of Internal Medicine, Division of Metabolism, Endocrinology & Diabetes, University of Michigan. Earlier in academia at Dalhousie University, Halifax, Canada, he was Professor of Medicine and Biochemistry and Head, Division of Endocrinology & Metabolism. He was also Head, Department of Medicine, Halifax Infirmary and Camp Hill Medical Center. After leaving Dalhousie, he became Medical Director of Diabetes Disease Management at Becton Dickinson and Company. Later, he was a Distinguished Medical Fellow at Lilly Research Laboratories and Senior Global Medical Director, Diabetes Endocrine Platform Team at Eli Lilly and Company. His research interests span from unravelling the biology of skeletal muscle to uncovering new knowledge on pharmacotherapy for people with diabetes and dyslipidemias. He has published over 200 research/clinical papers and chapters on diabetes, lipoprotein metabolism, and endocrinology. He was the inaugural Editor-in-Chief of Clinical Diabetes and Endocrinology. He is past President of the Canadian Diabetes Association, Chair of the Canadian Diabetes Advisory Board, and Vice-President of the International Diabetes Federation. He received the Harold Rifkin Award from the American Diabetes Association and the Charles H Best Award from the Canadian Diabetes Association.